Pharmacology Corner

Pharmacology education for healthcare professionals

  • Animations
  • Psychopharmacology
  • PowerPoints
  • About
Menu
  • Animations
  • Psychopharmacology
  • PowerPoints
  • About

Tag: VEGF

FDA approves bevacizumab (Avastin) for glioblastoma multiforme

Prescribing information, mechanism of action, approved indications and videos on Avastin (bevacizumab) for glioblastoma multiforme.

Off-label intravitreal use of bevacizumab (Avastin): reports of ocular side effects

Letter from Roche to health care professionals dated December 16, 2008. Related to off- label uses in ophtalmology of bevacizumab (Avastin): Reports of Eye Inflammation, Endophthalmitis, and Toxic Anterior Segment Syndrome (TASS) Following Off-label Intravitreal Use of AVASTIN® (bevacizumab)

Pharmacology Corner

Pharmacology education for healthcare professionals

All rights reserved

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos